Haematology Practice Review, Issue 51
In this issue:
Update on therapies in first-line relapse of chronic lymphocytic leukaemia
Guideline on communication and support in chronic cancer care
Pregnancy after allogeneic haematopoietic cell transplantation
Optimising the post-CAR T monitoring period
Discontinuation of CML therapy: Which patients are ideal candidates?
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for non-transplant eligible patients
AHCT for diffuse large B-cell lymphoma after early therapy failure
FDA approves axatilimab-csfr for chronic graft-versus-host disease
EMA recommends granting a marketing authorisation for generic nilotinib
Improved technology for CAR T cell manufacture
August newsletter of the Australasian Lymphoma Alliance
Health equity: Are we missing the mark with CAR T cell therapy?
The Lymphoma and Related Diseases Registry Newsletter
Expert contributor
Professor Jeff Szer
Professor Jeff Szer AM (@marrow), is a member of the Clinical Haematology team at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. He is also Director of the Western and Central Melbourne Integrated Cancer Service and outgoing President of the World Marrow Donor Association. He established the first adult bone marrow transplant centre in […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.